Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 156 (7), 2024-2040

Early Detection of Pancreatic Cancer: Opportunities and Challenges

Affiliations
Review

Early Detection of Pancreatic Cancer: Opportunities and Challenges

Aatur D Singhi et al. Gastroenterology.

Abstract

Most patients with pancreatic ductal adenocarcinoma (PDAC) present with symptomatic, surgically unresectable disease. Although the goal of early detection of PDAC is laudable and likely to result in significant improvement in overall survival, the relatively low prevalence of PDAC renders general population screening infeasible. The challenges of early detection include identification of at-risk individuals in the general population who would benefit from longitudinal surveillance programs and appropriate biomarker and imaging-based modalities used for PDAC surveillance in such cohorts. In recent years, various subgroups at higher-than-average risk for PDAC have been identified, including those with familial risk due to germline mutations, a history of pancreatitis, patients with mucinous pancreatic cysts, and elderly patients with new-onset diabetes. The last 2 categories are discussed at length in terms of the opportunities and challenges they present for PDAC early detection. We also discuss current and emerging imaging modalities that are critical to identifying early, potentially curable PDAC in high-risk cohorts on surveillance.

Keywords: Biomarker; Pre-diagnostic; Risk Stratification.

Conflict of interest statement

Conflicts of interest:

A.D.S. = Foundation Medicine (honorarium)

E.J.K = Philips Healthcare (sponsored research agreement), GE Healthcare (in-kind grant)

Similar articles

See all similar articles

Cited by 3 PubMed Central articles

Publication types

MeSH terms

Substances

Feedback